International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages 722-729 , November 2009

HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death

  • Nara Kingkaew

      Affiliations

    • Vachira Hospital, Phuket, Thailand
    • ,
  • Burachat Sangtong

      Affiliations

    • Vachira Hospital, Phuket, Thailand
    • ,
  • Waraya Amnuaiphon

      Affiliations

    • Vachira Hospital, Phuket, Thailand
    • ,
  • Jessada Jongpaibulpatana

      Affiliations

    • Vachira Hospital, Phuket, Thailand
    • ,
  • Wiroj Mankatittham

      Affiliations

    • Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
    • ,
  • Somsak Akksilp

      Affiliations

    • Office of Disease Prevention and Control 7, Ubon Ratchathani, Thailand
    • ,
  • Chawin Sirinak

      Affiliations

    • Department of Health, Bangkok Metropolitan Administration, Bangkok, Thailand
    • ,
  • Sriprapa Nateniyom

      Affiliations

    • Thailand Ministry of Public Health, Nonthaburi, Thailand
    • ,
  • Channawong Burapat

      Affiliations

    • Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • ,
  • Wanitchaya Kittikraisak

      Affiliations

    • Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • Corresponding Author InformationCorresponding author. Tel.: +66 580 0669; fax: +66 591 2909.
    • ,
  • Patama Monkongdee

      Affiliations

    • Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • ,
  • Jay K. Varma

      Affiliations

    • Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • Centers for Disease Control and Prevention, Atlanta, GA, USA

Received 25 September 2008 ,Revised 14 November 2008 ,Accepted 26 November 2008.

References 

  1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva: World Health Organization; 2007.
  2. Iseman MD. Extrapulmonary tuberculosis in adults. In:  Iseman MD editors. A clinician's guide to tuberculosis. Philadelphia: Lippincott, Williams and Wilkins; 2000;p. 145–197
  3. World Health Organization . Treatment of tuberculosis: guidelines for national programmes. 3rd ed.. Geneva: World Health Organization; 2003;
  4. Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2002;6:879–886
  5. Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38:199–205
  6. Musellim B, Erturan S, Sonmez Duman E, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220–1223
  7. Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435–441
  8. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148:1292–1297
  9. Solomon SS, Kumarasamy N, Celentano DD, Yepthomi TH, Arvind VP, Solomon S. Trends in HIV-related morbidity among patients admitted to a South Indian tertiary hospital between 1997 and 2003. AIDS Care. 2006;18:366–370
  10. Cailhol J, Decludt B, Che D. Sociodemographic factors that contribute to the development of extrapulmonary tuberculosis were identified. J Clin Epidemiol. 2005;58:1066–1071
  11. Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res. 2004;120:277–289
  12. World Health Organization . Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Geneva: World Health Organization; 2006;
  13. Nateniyom S, Jittimanee SX, Wiriyakitjar D, Jittimanee S, Kaophaithool S, Varma JK. Provider-initiated HIV testing and counseling in tuberculosis clinics in Thailand. Int J Tuberc Lung Dis. 2008;12:955–961
  14. Varma JK, Wiriyakitjar D, Nateniyom S, Anuwatnonthakate A, Monkongdee P, Sumnapan S, et al. Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004–2005. Bull World Health Organ. 2007;85:586–592
  15. World Health Organization. World Health Organization South-East Asia Regional Office. Fourth review of the National Tuberculosis Programme in Thailand, 16–25 July 2007. New Delhi: World Health Organization; 2008.
  16. TB Cluster Bureau of AIDS TB and STIs. National TB program guidelines. Bangkok: Department of Diseases Control, Ministry of Public Health; 2005.
  17. Kourbatova EV, Leonard MK, Romero J, Kraft C, del Rio C, Blumberg HM. Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US. Eur J Epidemiol. 2006;21:715–721
  18. Sreeramareddy CT, Panduru KV, Verma SC, Joshi HS, Bates MN. Comparison of pulmonary and extrapulmonary tuberculosis in Nepal—a hospital-based retrospective study. BMC Infect Dis. 2008;8:8
  19. Chan-Yeung M, Noertjojo K, Chan SL, Tam CM. Sex differences in tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2002;6:11–18
  20. Thompson BC. The pathogenesis of tuberculosis of peripheral lymph nodes. A clinical study of 324 cases. Tubercle. 1940;1940:141
  21. Lam TH, Ho SY, Hedley AJ, Mark KH, Peto R. Mortality and smoking in Hong Kong: case–control study of all adult deaths in 1998. BMJ. 2001;323:1–6
  22. Holmes CB, Hausler H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis. 1998;2:96–104
  23. Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuber Lung Dis. 1996;77:391–400
  24. Martinez AN, Rhee JT, Small PM, Behr MA. Sex differences in the epidemiology of tuberculosis in San Francisco. Int J Tuberc Lung Dis. 2000;4:26–31
  25. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376–1395
  26. Kwara A, Roahen-Harrison S, Prystowsky E, Kissinger R, Adams R, Mathison J, et al. Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection. Int J Tuberc Lung Dis. 2005;9:785–793
  27. Akksilp S, Karnkwainpoing O, Wattanaamornkiat W, Viriyakitja D, Mongkongdee P, Sitti W, et al. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis. 2007;13:1001–1007
  28. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis. 2004;190:1670–1676
  29. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16:75–83
  30. Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, Wattanaamornkiat W, et al. Anti-retroviral therapy for HIV-infected TB patients saves lives, but needs to be used more frequently in Thailand. J Acquir Immune Defic Syndr. 2008;48:181–189
  31. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, et al. Efficacy of trimethoprim–sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d’Ivoire: a randomised controlled trial. Lancet. 1999;353:1469–1475
  32. Trinh TT, Shah NS, Mai HA, Do TN, Duong T, Truong L, et al. HIV-associated TB in An Giang Province, Vietnam, 2001–2004: epidemiology and TB treatment outcomes. PLoS ONE. 2007;2:e507
  33. Mwaungulu FB, Floyd S, Crampin AC, Kasimba S, Malema S, Kanyongoloka H, et al. Co-trimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ. 2004;82:854–863
  34. Boeree MJ, Sauvageot D, Banda HT, Harries AD, Zijlstra EE. Efficacy and safety of two dosages of co-trimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis. Trop Med Int Health. 2005;10:723–733
  35. Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF. Effectiveness of co-trimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS. 2005;19:163–168
  36. Garcia de Olalla P, Martinez-Gonzalez MA, Cayla JA, Jansa JM, Iglesias B, Guerrero R, et al. Barcelona AIDS-TB Study Group Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis. 2002;6:1051–1057
  37. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculosis meningitis: a 30-year review. Clin Infect Dis. 1993;17:987–994
  38. Harries A, Maher D, Graham S. TB/HIV: a clinical manual. 2nd ed.. Geneva: World Health Organization; 2004;
  39. US National Institutes of Health. Clinical trials. Available at: www.clinicaltrials.gov (accessed January 2009).

PII: S1201-9712(09)00004-6

doi: 10.1016/j.ijid.2008.11.013

International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages 722-729 , November 2009

Article Tools

* Image Usage & Resolution